Meta tags:
description=Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. Our main activities include drug development, drug manufacturing and digital health investment.;

Headings (most frequently used words):

establishing, tomorrow, standard, of, care, history,

Text of the page (most frequently used words):
and (15), debiopharm (13), development (9), drug (8), with (7), for (6), the (6), manufacturing (6), our (6), discover (5), corporate (5), company (5), press (4), releases (4), media (4), life (4), responsibility (4), team (4), investment (4), fund (4), patients (3), their (3), quality (3), awards (3), grants (3), contact (3), more (3), expertise (3), active (3), research (3), digital (3), health (3), innovation (3), glance (3), made (2), passion (2), manage (2), cookies (2), that (2), aim (2), demain (2), mauvernay (2), were (2), dedicated (2), now (2), parent (2), products (2), licensing (2), innovative (2), commitment (2), develop (2), tomorrow (2), standard (2), care (2), share (2), leadership (2), pipeline (2), 2026, terms, conditions, privacy, policy, code, conduct, legal, notice, latest, announcements, journalists, every, make, benefit, each, year, recognize, several, projects, works, improving, access, find, inquiries, download, resources, library, learn, through, positively, contribute, society, environment, about, apres, together, his, son, thierry, they, able, build, professionals, broad, range, group, three, companies, international, science, division, après, asset, diversification, philanthropy, story, began, 1979, when, rolland, yves, convinced, many, useful, therapeutic, abandoned, before, reaching, full, potential, decided, establish, compounds, developing, them, into, medicines, out, having, launched, this, unique, business, model, staff, only, people, today, 420, employees, are, variety, roles, within, smart, data, start, ups, than, years, have, been, driven, same, bringing, solutions, history, antoine, exupéry, your, task, not, foresee, future, but, enable, independent, biopharmaceutical, based, switzerland, ongoing, cure, cancer, infectious, diseases, improve, patient, main, activities, include, establishing, purpose, application, warning, false, job, advertisement, recruitment, email, read, strategic, production, facility, oncology, bacterial, infections, career, technology, news, portfolio, approach, publications, work,

Text of the page (random words):
debiopharm we develop for patients and their quality of life the company our expertise press releases awards grants corporate responsibility work with us drug development at a glance pipeline products publications leadership team debiopharm innovation fund at a glance approach portfolio news team contact manufacturing research development at a glance technology pipeline leadership team awards grants corporate responsibility career press releases media manage cookies our parent company contact us our expertise discover drug development in oncology and bacterial infections discover manufacturing research development development and production facility discover debiopharm innovation fund strategic investment fund discover application warning false job advertisement and recruitment email read more share share purpose establishing tomorrow s standard of care debiopharm is an independent biopharmaceutical company based in switzerland with an ongoing commitment to develop tomorrow s standard of care to cure cancer infectious diseases and improve patient quality of life our main activities include drug development drug manufacturing and digital health investment your task is not to foresee the future but to enable it antoine de st exupéry history for more than 45 years we have been driven by the same commitment bringing innovative solutions to patients our story began in 1979 when dr rolland yves mauvernay convinced that many useful therapeutic products were abandoned before reaching their full potential decided to establish debiopharm a company dedicated to in licensing innovative compounds and developing them into medicines for out licensing having launched this unique business model with a staff of only 2 people today debiopharm s 420 employees are now active in a variety of roles within drug development drug manufacturing and investment in digital health and smart data start ups together with his son thierry mauvernay they were able to build a team of dedicated professionals with a broad range of expertise debiopharm is now a group of three companies active in drug development debiopharm international drug manufacturing debiopharm research manufacturing and digital health investment debiopharm innovation fund debiopharm is the life science division of our parent company après demain sa active in asset diversification and philanthropy about apres demain corporate responsibility through corporate responsibility we aim to positively contribute to society and the environment learn more media library find contact for media inquiries download corporate resources access awards and grants every development we make is for the benefit of patients each year we recognize several projects and works that aim at improving their quality of life discover press releases latest debiopharm s announcements for media and journalists press releases legal notice code of conduct manage cookies privacy policy terms conditions 2026 debiopharm made with passion by made it with passion